Product NDC: | 0378-5050 |
Proprietary Name: | Temazepam |
Non Proprietary Name: | temazepam |
Active Ingredient(s): | 30 mg/1 & nbsp; temazepam |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-5050 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA070920 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121025 |
Package NDC: | 0378-5050-05 |
Package Description: | 500 CAPSULE in 1 BOTTLE, PLASTIC (0378-5050-05) |
NDC Code | 0378-5050-05 |
Proprietary Name | Temazepam |
Package Description | 500 CAPSULE in 1 BOTTLE, PLASTIC (0378-5050-05) |
Product NDC | 0378-5050 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | temazepam |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20121025 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | TEMAZEPAM |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |